Side-by-side comparison of AI visibility scores, market position, and capabilities
New York City regulated utility (NYSE: ED) at $1,868M adjusted earnings (+6%); CECONY serves 3.6M electric/1.1M gas customers in NYC metro, Clean Energy Businesses sold $6.8B (2023), Manhattan grid electrification capex.
Consolidated Edison, Inc. is a New York City, New York-based regulated electric, gas, and steam utility holding company — publicly traded on the New York Stock Exchange (NYSE: ED) as an S&P 500 Utilities component — delivering electricity to approximately 3.6 million customers, natural gas to approximately 1.1 million customers, and steam to commercial and residential customers in Manhattan through two regulated utility subsidiaries: Consolidated Edison Company of New York (CECONY, serving New York City and Westchester County) and Orange and Rockland Utilities (serving counties in southern New York and northern New Jersey), through approximately 15,000 employees. In fiscal year 2024, Consolidated Edison reported adjusted earnings of $1,868 million ($5.40 per share), up from $1,762 million ($5.07 per share) in 2023 (+6%), demonstrating steady rate-base-driven earnings growth. GAAP net income was $1,820 million ($5.26/share) in 2024 versus $2,519 million ($7.25/share) in 2023, with the prior year's higher GAAP income reflecting the substantial gain from the $6.8 billion sale of Con Edison Clean Energy Businesses (its non-regulated renewable energy subsidiary) to RWE in 2023 — proceeds that Con Edison is deploying to reduce debt and fund its regulated infrastructure investment program. CEO Timothy Cawley leads the company's strategy of investing in Manhattan's grid infrastructure for reliability and electrification — particularly EV charging infrastructure, building electrification (replacing gas appliances with electric), and transmission upgrades for offshore wind power integration into the New York City grid.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.